Helen Diller Family Cancer Research Building

Call
Website
1450 3rd St
San Francisco, CA 94143
+1 (888) 689-8273
https://cancer.ucsf.edu

The Helen Diller Family Cancer Research Building in San Francisco, CA is a renowned facility dedicated to advancing cancer research and treatment. It provides a collaborative environment for scientists and medical professionals to conduct cutting-edge research in the fight against cancer.

With state-of-the-art laboratories and innovative technology, the Helen Diller Family Cancer Research Building plays a crucial role in the ongoing efforts to better understand and combat cancer. Through its work, the facility aims to improve patient outcomes and contribute to the global fight against this devastating disease.

Generated from their business information

Also at this address

Own this business?
See a problem?

You might also like

Anresco Laboratories
Laboratory equipment, except medical or dental, Business services, nec, nec, Product testing laboratories

Anresco Laboratories

1
"Avoid at all costs. Converted units incorrectly and would not make up for their mistake. Strategically pushed my issue to following week when they could not make calls. Still making excuses for..."
Biometrix
Cosmetology and personal hygiene salons

Biometrix

45
•
$
"First off, as for your time: that's really a judgement of you. My study paid me $40, for two visits over a four week period. The first time I turned it into a day date with my boyfriend - we..."
photo of Kailyn T.
Veracyte, Inc
Services, nec, nec, Testing laboratories

Veracyte, Inc

Veracyte is a leading molecular diagnostics company based in South San Francisco, CA, specializing in providing exceptional cancer care through advanced diagnostic tests. Their portfolio includes genomic sequencing classifiers for thyroid, prostate, breast, and bladder cancers, as well as an envisia genomic classifier for interstitial lung disease. Veracyte's tests empower clinicians with high-value insights, enabling more informed and confident decision-making in cancer diagnosis and treatment. With a proven framework and rigorous approach to diagnostics, Veracyte collaborates closely with clinicians and scientists to identify unmet needs and develop innovative solutions. Their tests have benefited over 400,000 patients worldwide, addressing the needs of the approximately 7 million people diagnosed with cancers that their tests target each year. By making leading diagnostics accessible globally, Veracyte aims to elevate the standard of care and transform cancer treatment for patients around the world.Generated from the website
United States›California›San Francisco›Helen Diller Family Cancer Research Building

Partial Data by Foursquare.